You have 9 free searches left this month | for more free features.

Proton Pump Inhibitor (PPI)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Eosinophilic Esophagitis Trial in Aurora (Omeprazole 20mg BID)

Recruiting
  • Eosinophilic Esophagitis
  • Omeprazole 20mg BID
  • Aurora, Colorado
    Children's Hospital Colorado
Jul 28, 2022

Gastroesophageal Reflux Trial (MHS-1031, Placebo)

Not yet recruiting
  • Gastroesophageal Reflux
  • (no location specified)
Dec 1, 2022

GERD Trial in Manchester (Body Surface Gastric Mapping)

Recruiting
  • GERD
  • Body Surface Gastric Mapping
  • Manchester, Greater Manchester, United Kingdom
    The Functional Gut Clinic
Jan 31, 2023

Delirium Related to Proton Pump Inhibitors Use

Completed
  • Proton Pump Inhibitor Adverse Reaction
  • +2 more
  • Caen, France
    Caen University Hospital
Apr 17, 2023

Healthy Volunteers Trial in Daytona Beach (LOXO-305, Omeprazole)

Completed
  • Healthy Volunteers
  • Daytona Beach, Florida
    Covance Clinical Research Unit
Nov 23, 2021

Post Prandial High Resolution Impedance- Manometry

Recruiting
  • Gastro-esophageal Reflux
  • Correlating the number of reflux episodes detected on 1-h post prandial esophageal high resolution manometry combined and those detected on ambulatory 24-h pH-impedance monitoring performed on PPI
  • Lyon, France
    Exploration Fonctionnelle Digestive, Hôpital Edouard Herriot, Ly
Mar 17, 2022

Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Shanghai Xuhui Central Hospital
Jun 24, 2023

Heartburn, Dyspepsia, Reflux Trial in Leuven (de-prescription of PPI via intermittent scheme, de-prescription of PPI via

Not yet recruiting
  • Heartburn
  • +2 more
  • de-prescription of PPI via intermittent scheme
  • +2 more
  • Leuven, Vlaams Brabant, Belgium
    Jan Tack
Nov 16, 2022

Non-erosive Reflux Disease, Gastroesophageal Reflux Trial in New Orleans (Proton Pump Inhibitor (PPI) Therapy, Sucralfate)

Terminated
  • Non-erosive Reflux Disease
  • Gastroesophageal Reflux
  • New Orleans, Louisiana
  • +1 more
Jan 25, 2022

Hypothyroidism;Postablative Trial in United States (levothyroxine sodium capsule, Proton pump inhibitor (PPI), Levothyroxine

Completed
  • Hypothyroidism;Postablative
  • levothyroxine sodium capsule
  • +2 more
  • La Jolla, California
  • +8 more
Apr 1, 2022

Gastric Lesion, Proton Pump Inhibitor Adverse Reaction, Probiotic Trial in Bari (Gastrus, Placebo)

Recruiting
  • Gastric Lesion
  • +2 more
  • Gastrus
  • Placebo
  • Bari, Italy
    Fernanda
Jul 29, 2022

Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection Trial in Goyang (7 day H.pylori eradication Omeprazole

Active, not recruiting
  • Helicobacter Pylori Infection
  • +2 more
  • 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin
  • Placebo, Omeprazole or Rabeprazole, Clarithromycin
  • Goyang, Gyeonggi, Korea, Republic of
    National Cancer Center, Korea
Apr 8, 2022

Proton Pump Inhibitor, Inappropriate Drug Use, Discontinuation Trial (Patient Journey App, Information folder)

Not yet recruiting
  • Proton Pump Inhibitor
  • +3 more
  • Patient Journey App
  • Information folder
  • (no location specified)
Apr 20, 2022

H2 Receptor Antagonist and Proton Pump Inhibitor on Positivity

Not yet recruiting
  • COVID-19
  • No intervention (Retrospective Cohort Observational)
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 6, 2021

Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)

Completed
  • Relapsed or Refractory Lymphoma
  • Itraconazole 200 mg
  • +3 more
  • Miami, Florida
    QPS- Miami
Jan 12, 2023

Proton Pump Inhibitors Trial in United States (PPI De-prescribing Program)

Completed
  • Proton Pump Inhibitors
  • PPI De-prescribing Program
  • West Haven, Connecticut
  • +3 more
Mar 7, 2022

Liver Cirrhosis Trial in Hamburg (Placebo, Esomeprazole 20mg)

Recruiting
  • Liver Cirrhosis
  • Placebo
  • Esomeprazole 20mg
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
May 3, 2021

Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)

Recruiting
  • Coronary Artery Disease
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Mar 6, 2022

Gastroesophageal Reflux Disease (GERD) Trial in Redmond (EsophyX System with SerosaFuse fasteners, PPI)

Completed
  • Gastroesophageal Reflux Disease (GERD)
  • EsophyX System with SerosaFuse fasteners
  • PPI
  • Redmond, Washington
    EndoGastric Solutions
Nov 6, 2020

Proton Pump Inhibitor, Primary Care Trial in Sesto San Giovanni, Milan, Napoli (Educational intervention)

Active, not recruiting
  • Proton Pump Inhibitor
  • Primary Care
  • Educational intervention
  • Sesto San Giovanni, Milan, Italy
  • +2 more
Sep 28, 2021

Helicobacter Pylori Infection Trial in Shanghai (Rabeprazole, Bismuth potassium citrate, Metronidazole)

Recruiting
  • Helicobacter Pylori Infection
  • Shanghai, Shanghai, China
    Zhongshan Hospital, Fudan University
Aug 20, 2021

Hepatic Encephalopathy Trial in Durham (PPI deprescribing)

Recruiting
  • Hepatic Encephalopathy
  • PPI deprescribing
  • Durham, North Carolina
    Duke University Hospital
Jan 23, 2023

Coronary Artery Disease Trial (Lansoprazole 15 mg)

Not yet recruiting
  • Coronary Artery Disease
  • Lansoprazole 15 mg
  • (no location specified)
Apr 6, 2023

Bioavailability, B-cell Lymphoid Cancer Trial in Baltimore (Treatment A- Part 1, Treatment B- Part 1, Treatment C - Part 1)

Completed
  • Bioavailability
  • B-cell Lymphoid Cancer
  • Treatment A- Part 1
  • +7 more
  • Baltimore, Maryland
    Research Site
Feb 2, 2021

Inappropriate Prescribing, Reflux Disease, Proton Pump Inhibitors Trial in Bern (Proton Pump Inhibitor deprescribing tool)

Not yet recruiting
  • Inappropriate Prescribing
  • +2 more
  • Proton Pump Inhibitor deprescribing tool
  • Bern, Switzerland
    Prof. Dr. med. Dr. phil. Sven Streit
Nov 8, 2023